Physician profile
Paul Dare
NPI 1073724910
$1,455.73
in general payments reported to CMS, 2019-2025
10 companies · $280 in 2025
The $280 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $28.32 · 2021: $132 · 2022: $222 · 2023: $85.17 · 2024: $355 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $661.03 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $256.20 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $191.88 | 2021-2025 | Sapien 3 Ultra Resilia, Konect Resilia |
| Merck Sharp & Dohme LLC | $115.04 | 2019 | |
| Zimmer Biomet Holdings, INC. | $76.96 | 2025 | Sternalock |
| Abbott Laboratories | $57.80 | 2021-2022 | |
| Ambu INC. | $38.64 | 2025 | |
| Medtronic, INC. | $21.88 | 2024 | Hawkone |
| Eagle Pharmaceuticals, INC. | $19.78 | 2023 | |
| Shockwave Medical, INC | $16.52 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Dare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.